Tocilizumab in Treatment for Patients With COVID-19

Chengliang Yang¹, Mingyao Liu^{1

2}

Affiliations

¹ Latner Thoracic Surgery Research Laboratories, Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.
² Institute of Medical Science, Departments of Surgery, Medicine and Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.

Comment

Chengliang Yang et al. JAMA Intern Med. 2021.

. 2021 Jul 1;181(7):1017-1018.

doi: 10.1001/jamainternmed.2021.0392.

Chengliang Yang¹, Mingyao Liu^{1

2}

¹ Latner Thoracic Surgery Research Laboratories, Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.
² Institute of Medical Science, Departments of Surgery, Medicine and Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.

No abstract available

Comment in

Tocilizumab in Treatment for Patients With COVID-19-Reply.
Salvarani C, Massari M, Facciolongo N. Salvarani C, et al. JAMA Intern Med. 2021 Jul 1;181(7):1019-1020. doi: 10.1001/jamainternmed.2021.0404. JAMA Intern Med. 2021. PMID: 33818607 No abstract available.

Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study.
Biran N, Ip A, Ahn J, Go RC, Wang S, Mathura S, Sinclaire BA, Bednarz U, Marafelias M, Hansen E, Siegel DS, Goy AH, Pecora AL, Sawczuk IS, Koniaris LS, Simwenyi M, Varga DW, Tank LK, Stein AA, Allusson V, Lin GS, Oser WF, Tuma RA, Reichman J, Brusco L Jr, Carpenter KL, Costanzo EJ, Vivona V, Goldberg SL. Biran N, et al. Lancet Rheumatol. 2020 Oct;2(10):e603-e612. doi: 10.1016/S2665-9913(20)30277-0. Epub 2020 Aug 14. Lancet Rheumatol. 2020. PMID: 32838323 Free PMC article.
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
Salvarani C, Dolci G, Massari M, Merlo DF, Cavuto S, Savoldi L, Bruzzi P, Boni F, Braglia L, Turrà C, Ballerini PF, Sciascia R, Zammarchi L, Para O, Scotton PG, Inojosa WO, Ravagnani V, Salerno ND, Sainaghi PP, Brignone A, Codeluppi M, Teopompi E, Milesi M, Bertomoro P, Claudio N, Salio M, Falcone M, Cenderello G, Donghi L, Del Bono V, Colombelli PL, Angheben A, Passaro A, Secondo G, Pascale R, Piazza I, Facciolongo N, Costantini M; RCT-TCZ-COVID-19 Study Group. Salvarani C, et al. JAMA Intern Med. 2021 Jan 1;181(1):24-31. doi: 10.1001/jamainternmed.2020.6615. JAMA Intern Med. 2021. PMID: 33080005 Free PMC article. Clinical Trial.